A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.

Limited clinical benefits derived from anti-VEGF therapy have driven the identification of new targets involved in tumor angiogenesis. Here, we report an integrative meta-analysis to define the transcriptional program underlying angiogenesis in human cancer. This approach identified ELTD1, an orphan...

Full description

Bibliographic Details
Main Authors:	Masiero, M, Simões, F, Han, H, Snell, C, Peterkin, T, Bridges, E, Mangala, L, Wu, S, Pradeep, S, Li, D, Han, C, Dalton, H, Lopez-Berestein, G, Tuynman, J, Mortensen, N, Li, J, Patient, R, Sood, A, Banham, A, Harris, A, Buffa, F
Format:	Journal article
Language:	English
Published:	Elsevier 2013

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis by Masiero, M, Simões, F, Han, H, Snell, C, Peterkin, T, Bridges, E, Mangala, L, Wu, S, Pradeep, S, Li, D, Han, C, Dalton, H, Lopez-Berestein, G, Tuynman, J, Mortensen, N, Li, J, Patient, R, Sood, A, Banham, A, Harris, A, Buffa, F

Published 2013

Journal article

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.

Similar Items